Filing Details
- Accession Number:
- 0000905148-25-000867
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-05 18:23:14
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-03-05
- Accepted Time:
- 2025-03-05 18:23:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1839341 | Core Scientific Inc. | CORZ | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1447586 | A Todd Becker | C/O Core Scientific, Inc. 838 Walker Road, Suite 21-2105 Dover DE 19904 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-03 | 134,250 | $10.75 | 195,687 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Tranche 1 Warrants | Disposition | 2025-03-03 | 10,763 | $5.57 | 10,763 | $6.81 |
| Common Stock | Tranche 2 Warrants | Disposition | 2025-03-03 | 3,900 | $10.86 | 3,900 | $0.01 |
| Common Stock | Tranche 2 Warrants | Disposition | 2025-03-04 | 5,069 | $9.89 | 5,069 | $0.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-01-23 | 2027-01-23 | No | 4 | S | Direct |
| 5,069 | 2029-01-23 | No | 4 | S | Direct | |
| 0 | 2029-01-23 | No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
- The price reported is a weighted average price. These Tranche 1 Warrants were sold in multiple transactions at prices ranging from $5.56 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 1 Warrants sold at each separate price within such range.
- Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.
- The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $10.75 to $10.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.
- The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $9.7867 to $9.955, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.
Billionaire Hedge Funds
